Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 23845195)

1.

Towards the eradication of HPV infection through universal specific vaccination.

Crosignani P, De Stefani A, Fara GM, Isidori AM, Lenzi A, Liverani CA, Lombardi A, Mennini FS, Palu' G, Pecorelli S, Peracino AP, Signorelli C, Zuccotti GV.

BMC Public Health. 2013 Jul 11;13:642. doi: 10.1186/1471-2458-13-642. Review.

2.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Nov 22;31 Suppl 8:I1-31. doi: 10.1016/j.vaccine.2013.07.026. Review.

3.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001. Review.

PMID:
24331745
4.

Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.

Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000.

PMID:
21838332
5.

Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.

Ault K, Reisinger K.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S26-8. doi: 10.1016/S1201-9712(07)60018-6. Review.

6.

Prevention strategies against human papillomavirus in males.

Garland SM.

Gynecol Oncol. 2010 May;117(2 Suppl):S20-5. doi: 10.1016/j.ygyno.2010.01.027. Epub 2010 Feb 16. Review.

PMID:
20138347
7.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

8.

Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?

Low GM, Attiga YS, Garg G, Schlegal R, Gallicano GI.

Viral Immunol. 2012 Jun;25(3):174-86. doi: 10.1089/vim.2011.0083. Review. Erratum in: Viral Immunol. 2012 Aug;25(4):345.

PMID:
22691099
9.

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.

Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J.

BMC Cancer. 2013 Jan 8;13:10. doi: 10.1186/1471-2407-13-10.

10.

Public health issues related to HPV vaccination.

Hershey JH, Velez LF.

J Public Health Manag Pract. 2009 Sep-Oct;15(5):384-92. doi: 10.1097/PHH.0b013e3181a23de6. Review.

PMID:
19704306
11.

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.

Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA.

Vaccine. 2012 Nov 20;30 Suppl 5:F1-11. doi: 10.1016/j.vaccine.2012.05.090. Review.

PMID:
23199951
12.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

13.

Cancers attributable to human papillomavirus infection.

Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.

Sex Health. 2010 Sep;7(3):244-52. doi: 10.1071/SH10020.

PMID:
20719211
14.

An overview on the implementation of HPV vaccination in Europe.

Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, Panatto D, Gasparini R, Boccalini S.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:128-35. Epub 2011 Jan 1. Review.

15.

Update on vaccination clinical trials for HPV-related disease.

Erickson BK, Landers EE, Huh WK.

Clin Ther. 2014 Jan 1;36(1):8-16. doi: 10.1016/j.clinthera.2013.11.003. Review.

PMID:
24417781
16.

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.

Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N.

BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136.

17.

[Vaccines against human papillomavirus (HPV); between registration and implementation].

van Rossum TG, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J.

Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):987-92. Review. Dutch.

PMID:
18549172
18.

Human papillomavirus vaccine: a paradigm shift for pediatricians.

Jenson HB.

Curr Opin Pediatr. 2009 Feb;21(1):112-21. doi: 10.1097/MOP.0b013e3283207f93. Review.

PMID:
19242247
19.

Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.

Pharmacotherapy. 2011 Mar;31(3):280-97. doi: 10.1592/phco.31.3.280. Review.

PMID:
21361739
20.

Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Oct 14;60(40):1382-4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk